Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Taxes: 2022-2025

Historic Change in Taxes for Sunshine Biopharma (SBFM) over the last 3 years, with Sep 2025 value amounting to $162,992.

  • Sunshine Biopharma's Change in Taxes fell 68.66% to $162,992 in Q3 2025 from the same period last year, while for Sep 2025 it was $68,422, marking a year-over-year decrease of 75.85%. This contributed to the annual value of -$812,080 for FY2024, which is 1008.69% down from last year.
  • Sunshine Biopharma's Change in Taxes amounted to $162,992 in Q3 2025, which was up 442.53% from $30,043 recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Change in Taxes ranged from a high of $1.0 million in Q4 2023 and a low of -$1.2 million during Q2 2024.
  • Over the past 3 years, Sunshine Biopharma's median Change in Taxes value was -$40,161 (recorded in 2025), while the average stood at -$66,587.
  • In the last 5 years, Sunshine Biopharma's Change in Taxes skyrocketed by 323.55% in 2023 and then crashed by 530.84% in 2024.
  • Over the past 4 years, Sunshine Biopharma's Change in Taxes (Quarterly) stood at $238,679 in 2022, then soared by 323.55% to $1.0 million in 2023, then tumbled by 108.35% to -$84,452 in 2024, then plummeted by 68.66% to $162,992 in 2025.
  • Its Change in Taxes was $162,992 in Q3 2025, compared to $30,043 in Q2 2025 and -$40,161 in Q1 2025.